Search research articles
Contact Us
Filters
Showing results (31-40 of 79) with videos related to
Page
of 8
Sort By:
The American Journal of Gastroenterology
|
June 23, 2026
PREVALENCE AND RISK FACTORS ASSOCIATED WITH MASLD AND ADVANCED FIBROSIS AMONG OVERWEIGHT INDIVIDUALS: IMPLICATIONS FOR SCREENING GUIDELINES
Maria Mironova, Kaleb Tesfai, Egbert Madamba, et al.
Journal of Hepatology
|
June 15, 2025
Clinical utility of phosphatidylethanol to detect underreported alcohol use and enhance steatotic liver disease subclassification
Federica Tavaglione, Luis Antonio Díaz, Veeral Ajmera, et al.
Gastro Hep Advances
|
July 6, 2026
Longitudinal Validation of Clinical Care Pathways for Metabolic Dysfunction-Associated Steatotic Liver Disease in a Prospective Cohort of Individuals With Type 2 Diabetes
Jonathan Dounel, Luis Antonio Díaz, Ricki Bettencourt, et al.
European Journal of Gastroenterology & Hepatology
|
July 6, 2018
Treatment of hepatitis C with direct-acting antivirals significantly reduces liver-related hospitalizations in patients with cirrhosis
Lucas A Hill, Ronnie J Delmonte, Barbara Andrews, et al.
JHEP Reports : Innovation in Hepatology
|
February 20, 2026
Factors associated with protection from MASLD in type 2 diabetes: A prospective study integrating longitudinal MRI/MRE and stable isotope tracing
Federica Tavaglione, Veeral Ajmera, Luis Antonio Díaz, et al.
Hepatology (Baltimore, Md.)
|
October 20, 2023
Validation of AGA clinical care pathway and AASLD practice guidance for nonalcoholic fatty liver disease in a prospective cohort of patients with type 2 diabetes
Veeral Ajmera, Kaleb Tesfai, Erick Sandoval, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 18, 2019
Prospective, Same-Day, Direct Comparison of Controlled Attenuation Parameter With the M vs the XL Probe in Patients With Nonalcoholic Fatty Liver Disease, Using Magnetic Resonance Imaging-Proton Density Fat Fraction as the Standard
Cyrielle Caussy, Justine Brissot, Seema Singh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 18, 2019
Liver Stiffness Severity is Associated With Increased Cardiovascular Risk in Patients With Type 2 Diabetes
Neeraj Mangla, Veeral H Ajmera, Cyrielle Caussy, et al.
Journal of Clinical Gastroenterology
|
January 31, 2025
Focused Recommendations for the Management of Metabolic Dysfunction-Associated Steatohepatitis (MASH) by Advanced Practice Providers in the United States
Brian P Lam, Jessica Bartholomew, Sherona Bau, et al.
Journal of Hepatology
|
November 21, 2022
A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes
Veeral Ajmera, Sandra Cepin, Kaleb Tesfai, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 79) with videos related to
Sort By:
Page
of 8
The American Journal of Gastroenterology
|
June 23, 2026
PREVALENCE AND RISK FACTORS ASSOCIATED WITH MASLD AND ADVANCED FIBROSIS AMONG OVERWEIGHT INDIVIDUALS: IMPLICATIONS FOR SCREENING GUIDELINES
Maria Mironova, Kaleb Tesfai, Egbert Madamba, et al.
Journal of Hepatology
|
June 15, 2025
Clinical utility of phosphatidylethanol to detect underreported alcohol use and enhance steatotic liver disease subclassification
Federica Tavaglione, Luis Antonio Díaz, Veeral Ajmera, et al.
Gastro Hep Advances
|
July 6, 2026
Longitudinal Validation of Clinical Care Pathways for Metabolic Dysfunction-Associated Steatotic Liver Disease in a Prospective Cohort of Individuals With Type 2 Diabetes
Jonathan Dounel, Luis Antonio Díaz, Ricki Bettencourt, et al.
European Journal of Gastroenterology & Hepatology
|
July 6, 2018
Treatment of hepatitis C with direct-acting antivirals significantly reduces liver-related hospitalizations in patients with cirrhosis
Lucas A Hill, Ronnie J Delmonte, Barbara Andrews, et al.
JHEP Reports : Innovation in Hepatology
|
February 20, 2026
Factors associated with protection from MASLD in type 2 diabetes: A prospective study integrating longitudinal MRI/MRE and stable isotope tracing
Federica Tavaglione, Veeral Ajmera, Luis Antonio Díaz, et al.
Hepatology (Baltimore, Md.)
|
October 20, 2023
Validation of AGA clinical care pathway and AASLD practice guidance for nonalcoholic fatty liver disease in a prospective cohort of patients with type 2 diabetes
Veeral Ajmera, Kaleb Tesfai, Erick Sandoval, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 18, 2019
Prospective, Same-Day, Direct Comparison of Controlled Attenuation Parameter With the M vs the XL Probe in Patients With Nonalcoholic Fatty Liver Disease, Using Magnetic Resonance Imaging-Proton Density Fat Fraction as the Standard
Cyrielle Caussy, Justine Brissot, Seema Singh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 18, 2019
Liver Stiffness Severity is Associated With Increased Cardiovascular Risk in Patients With Type 2 Diabetes
Neeraj Mangla, Veeral H Ajmera, Cyrielle Caussy, et al.
Journal of Clinical Gastroenterology
|
January 31, 2025
Focused Recommendations for the Management of Metabolic Dysfunction-Associated Steatohepatitis (MASH) by Advanced Practice Providers in the United States
Brian P Lam, Jessica Bartholomew, Sherona Bau, et al.
Journal of Hepatology
|
November 21, 2022
A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes
Veeral Ajmera, Sandra Cepin, Kaleb Tesfai, et al.
Page
of 8